Lv11
36 积分 2024-09-19 加入
Outcomes following FGFR Inhibitor Therapy in Patients with Cholangiocarcinoma
5小时前
已完结
Female CEOs and the compensation of other top managers
1个月前
已完结
At the crossroads of immunotherapy for oncogene-addicted subsets of NSCLC
1个月前
已完结
Unraveling the prevalence of various signalling pathways in non-small-cell lung cancer: a review
2个月前
已完结
Second-line Treatment Strategy in Unresectable Hepatocellular Carcinoma After First-line Atezolizumab Plus Bevacizumab
6个月前
已完结
Milvexian a novel factor XIa inhibitor for stroke prevention: pharmacokinetic and pharmacodynamic evaluation
6个月前
已完结
A PTK7-targeted antibody-drug conjugate reduces tumor-initiating cells and induces sustained tumor regressions
7个月前
已完结
Systematic analysis of levels of evidence supporting Chinese clinical practice guidelines for gastrointestinal disease
7个月前
已完结
皖公网安备34019202002308
